Cargando…
Targeting RB1 Loss in Cancers
SIMPLE SUMMARY: Irreversible defects in RB1 tumor suppressor functions often predict poor outcomes in cancer patients. However, the RB1-defecient status can be a benefit as well for them, as it generates a variety of vulnerabilities induced through the upregulation of RB1 targets, relief from functi...
Autores principales: | Linn, Paing, Kohno, Susumu, Sheng, Jindan, Kulathunga, Nilakshi, Yu, Hai, Zhang, Zhiheng, Voon, Dominic, Watanabe, Yoshihiro, Takahashi, Chiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345210/ https://www.ncbi.nlm.nih.gov/pubmed/34359636 http://dx.doi.org/10.3390/cancers13153737 |
Ejemplares similares
-
Peripubertal high‐fat diet promotes c‐Myc stabilization in mammary gland epithelium
por: Kulathunga, Nilakshi, et al.
Publicado: (2020) -
Tumor Milieu Controlled by RB Tumor Suppressor
por: Kitajima, Shunsuke, et al.
Publicado: (2020) -
Loss of Rb1 by epigenetic modification regulates expansion of MDSC in cancer
por: Youn, Je-In, et al.
Publicado: (2014) -
RB depletion is required for the continuous growth of tumors initiated by loss of RB
por: Doan, Alex, et al.
Publicado: (2021) -
The vulnerability of RB loss in breast cancer: Targeting a void in cell cycle control
por: Knudsen, Erik S., et al.
Publicado: (2018)